Press releases

Regulatory press release 2023-05-30

Xspray has published prospectus relating to its previously announced rights issue

Regulatory press release 2023-05-30

The Board of Directors of Xspray has resolved on a previously announced rights issue of units of approximately SEK 300 million ahead of Dasynoc product launch

Regulatory press release 2023-05-25

Bulletin from the extraordinary general meeting of Xspray Pharma AB (publ)

Regulatory press release 2023-05-16

Bulletin from the 2023 annual general meeting of Xspray Pharma AB (publ)

Regulatory press release 2023-05-04

Interim Report First Quarter 2023

All press releases

Latest report
Interim Report Q1 2023
Subscribe
Get our latest press releases and reports
Subscribe
Submit to our press releases and get an email every time we publish a press release or report on our website.
Type*
Reports
Press releases
E-mail*

Välj språk*
Swedish
English
When clicked on Send I agree that my personal information will be saved. Read more
Phone
This field is for validation purposes and should be left unchanged.

Press contact

Kerstin Hasselgren, Chief Financial Officer

+46 (0)70 311 16 83

info@xspray.com

Presentations and interviews

VD Per Andersson intervjuas om planerna för verksamheten med anledning av den föreslagna nyemissionen

Interview with Kerstin Hasselgren at Redeye Life Science Day, November 24, 2022

Capital Markets Day, May 24, 2022

Interview with Per Andersson at Pareto, October 18, 2021

Media